Literature DB >> 7598513

Antagonists of neuronal calcium channels: structure, function, and therapeutic implications.

G P Miljanich1, J Ramachandran.   

Abstract

This article reviews the structural and functional diversity of neuronal calcium channels and the therapeutic potential of antagonizing such channels. Through spatial and temporal control of intracellular calcium concentration, voltage-sensitive calcium channels regulate a host of neuronal processes, including neurotransmitter secretion, electrical activity, cytoskeletal function, cell metabolism and proliferation, and gene expression. Several genes elaborate a number of calcium channel isoforms or subtypes--each tailored to specific roles in neuronal function and possessing distinct biophysical properties, distribution, modulation, and pharmacological sensitivity. This diversity has raised the possibility that subtype-specific antagonists could provide novel treatments for some neuropathologies. In fact, neuroprotective and analgesic actions of N-type channel blockers in animals appear to confirm this supposition. These properties prompted human clinical studies evaluating these agents for prevention of neuronal degeneration following ischemic brain trauma and for relief of pain. Future medical applications for these blockers and antagonists of other channels subtypes are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598513     DOI: 10.1146/annurev.pa.35.040195.003423

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  45 in total

1.  Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatum.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Alternative splicing of a short cassette exon in alpha1B generates functionally distinct N-type calcium channels in central and peripheral neurons.

Authors:  Z Lin; Y Lin; S Schorge; J Q Pan; M Beierlein; D Lipscombe
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

3.  Developmental changes in calcium channel types mediating central synaptic transmission.

Authors:  S Iwasaki; A Momiyama; O D Uchitel; T Takahashi
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1-42)) abolishes calcium influx via N-type calcium channels.

Authors:  J Kasparová; V Lisá; S Tucek; V Dolezal
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

5.  Solution structure and backbone dynamics of an omega-conotoxin precursor.

Authors:  D P Goldenberg; R E Koehn; D E Gilbert; G Wagner
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

6.  Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model : real time estimation of glutamate.

Authors:  Seok Keun Choi; Gi-Ja Lee; Samjin Choi; Youn Jung Kim; Hun-Kuk Park; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

7.  Differential expression of membrane conductances underlies spontaneous event initiation by rostral midline neurons in the embryonic mouse hindbrain.

Authors:  Audrey M Moruzzi; Nauzley C Abedini; Matthew A Hansen; Julia E Olson; Martha M Bosma
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

8.  High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.

Authors:  P Eller; S Berjukov; S Wanner; I Huber; S Hering; H G Knaus; G Toth; S D Kimball; J Striessnig
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

9.  Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals.

Authors:  R E Westenbroek; L Hoskins; W A Catterall
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

10.  Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.

Authors:  Maciej Gasior; Natalie A White; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2007-08-23       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.